nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—Olsalazine—ulcerative colitis	0.18	1	CrCtD
Mesalazine—Crohn's disease—ulcerative colitis	0.141	1	CtDrD
Mesalazine—Aminosalicylic Acids—Olsalazine—ulcerative colitis	0.124	0.429	CiPCiCtD
Mesalazine—Aminosalicylic Acids—Balsalazide—ulcerative colitis	0.0943	0.325	CiPCiCtD
Mesalazine—Aminosalicylic Acids—Sulfasalazine—ulcerative colitis	0.0715	0.246	CiPCiCtD
Mesalazine—Diflunisal—Olsalazine—ulcerative colitis	0.0393	0.399	CrCrCtD
Mesalazine—MPO—ulcerative colitis	0.0354	0.343	CbGaD
Mesalazine—Olsalazine—Balsalazide—ulcerative colitis	0.0337	0.342	CrCrCtD
Mesalazine—PPARG—ulcerative colitis	0.0314	0.304	CbGaD
Mesalazine—Olsalazine—Sulfasalazine—ulcerative colitis	0.0255	0.259	CrCrCtD
Mesalazine—PTGS1—ulcerative colitis	0.0232	0.225	CbGaD
Mesalazine—CHUK—Sulfasalazine—ulcerative colitis	0.0186	0.137	CbGbCtD
Mesalazine—ALOX5—Olsalazine—ulcerative colitis	0.0182	0.134	CbGbCtD
Mesalazine—PPARG—Olsalazine—ulcerative colitis	0.0162	0.119	CbGbCtD
Mesalazine—ALOX5—Balsalazide—ulcerative colitis	0.0162	0.119	CbGbCtD
Mesalazine—PPARG—Balsalazide—ulcerative colitis	0.0145	0.106	CbGbCtD
Mesalazine—IKBKB—Sulfasalazine—ulcerative colitis	0.0134	0.099	CbGbCtD
Mesalazine—PTGS2—ulcerative colitis	0.0133	0.128	CbGaD
Mesalazine—ALOX5—Sulfasalazine—ulcerative colitis	0.00724	0.0533	CbGbCtD
Mesalazine—PPARG—Sulfasalazine—ulcerative colitis	0.00646	0.0476	CbGbCtD
Mesalazine—PTGS2—Olsalazine—ulcerative colitis	0.00484	0.0356	CbGbCtD
Mesalazine—MPO—superior mesenteric artery—ulcerative colitis	0.00472	0.504	CbGeAlD
Mesalazine—PTGS2—Balsalazide—ulcerative colitis	0.00431	0.0318	CbGbCtD
Mesalazine—PTGS1—Olsalazine—ulcerative colitis	0.00409	0.0301	CbGbCtD
Mesalazine—PTGS1—Balsalazide—ulcerative colitis	0.00364	0.0268	CbGbCtD
Mesalazine—PTGS2—Triamcinolone—ulcerative colitis	0.00193	0.0142	CbGbCtD
Mesalazine—PTGS2—Sulfasalazine—ulcerative colitis	0.00193	0.0142	CbGbCtD
Mesalazine—PTGS2—Betamethasone—ulcerative colitis	0.00165	0.0122	CbGbCtD
Mesalazine—PTGS1—Sulfasalazine—ulcerative colitis	0.00163	0.012	CbGbCtD
Mesalazine—PTGS2—Dexamethasone—ulcerative colitis	0.000962	0.00708	CbGbCtD
Mesalazine—CHUK—epithelium—ulcerative colitis	0.000402	0.0428	CbGeAlD
Mesalazine—CHUK—lymphoid tissue—ulcerative colitis	0.000309	0.033	CbGeAlD
Mesalazine—CHUK—digestive system—ulcerative colitis	0.000305	0.0326	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—ulcerative colitis	0.000263	0.0281	CbGeAlD
Mesalazine—CHUK—liver—ulcerative colitis	0.000228	0.0243	CbGeAlD
Mesalazine—ALOX5—smooth muscle tissue—ulcerative colitis	0.000218	0.0232	CbGeAlD
Mesalazine—IKBKB—lymphoid tissue—ulcerative colitis	0.00021	0.0224	CbGeAlD
Mesalazine—IKBKB—digestive system—ulcerative colitis	0.000208	0.0221	CbGeAlD
Mesalazine—MPO—epithelium—ulcerative colitis	0.000191	0.0204	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—ulcerative colitis	0.000174	0.0186	CbGeAlD
Mesalazine—ALOX5—digestive system—ulcerative colitis	0.000172	0.0184	CbGeAlD
Mesalazine—PPARG—epithelium—ulcerative colitis	0.00017	0.0181	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—ulcerative colitis	0.000164	0.0175	CbGeAlD
Mesalazine—IKBKB—liver—ulcerative colitis	0.000155	0.0165	CbGeAlD
Mesalazine—Olsalazine—IFNG—ulcerative colitis	0.000153	0.183	CrCbGaD
Mesalazine—MPO—lymphoid tissue—ulcerative colitis	0.000147	0.0157	CbGeAlD
Mesalazine—MPO—digestive system—ulcerative colitis	0.000146	0.0155	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—ulcerative colitis	0.000131	0.014	CbGeAlD
Mesalazine—PPARG—digestive system—ulcerative colitis	0.000129	0.0138	CbGeAlD
Mesalazine—ALOX5—liver—ulcerative colitis	0.000128	0.0137	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000111	0.247	CbGdCrCtD
Mesalazine—MPO—liver—ulcerative colitis	0.000108	0.0116	CbGeAlD
Mesalazine—PPARG—liver—ulcerative colitis	9.63e-05	0.0103	CbGeAlD
Mesalazine—PTGS1—epithelium—ulcerative colitis	9.08e-05	0.00968	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—ulcerative colitis	8.75e-05	0.00933	CbGeAlD
Mesalazine—PTGS2—epithelium—ulcerative colitis	8.68e-05	0.00926	CbGeAlD
Mesalazine—PTGS2—smooth muscle tissue—ulcerative colitis	8.36e-05	0.00892	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS1—ulcerative colitis	7.76e-05	0.093	CrCbGaD
Mesalazine—Aminosalicylic Acid—MPO—ulcerative colitis	7.63e-05	0.0914	CrCbGaD
Mesalazine—Olsalazine—PPARG—ulcerative colitis	7.21e-05	0.0863	CrCbGaD
Mesalazine—PTGS1—digestive system—ulcerative colitis	6.91e-05	0.00737	CbGeAlD
Mesalazine—PTGS2—lymphoid tissue—ulcerative colitis	6.68e-05	0.00713	CbGeAlD
Mesalazine—PTGS2—digestive system—ulcerative colitis	6.6e-05	0.00704	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	5.35e-05	0.119	CbGdCrCtD
Mesalazine—Olsalazine—PTGS1—ulcerative colitis	5.32e-05	0.0637	CrCbGaD
Mesalazine—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	5.26e-05	0.118	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	5.26e-05	0.118	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	5.14e-05	0.115	CbGdCrCtD
Mesalazine—Diflunisal—PTGS1—ulcerative colitis	5e-05	0.0599	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS1—ulcerative colitis	5e-05	0.0599	CrCbGaD
Mesalazine—PTGS2—liver—ulcerative colitis	4.92e-05	0.00525	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—ulcerative colitis	4.44e-05	0.0531	CrCbGaD
Mesalazine—Dopamine—SLC22A5—ulcerative colitis	4.25e-05	0.0509	CrCbGaD
Mesalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	3.23e-05	0.0721	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	3.18e-05	0.071	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	3.18e-05	0.071	CbGdCrCtD
Mesalazine—Droxidopa—ADRB2—ulcerative colitis	3.16e-05	0.0378	CrCbGaD
Mesalazine—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	3.1e-05	0.0693	CbGdCrCtD
Mesalazine—Olsalazine—PTGS2—ulcerative colitis	3.04e-05	0.0364	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—ulcerative colitis	2.86e-05	0.0342	CrCbGaD
Mesalazine—Diflunisal—PTGS2—ulcerative colitis	2.86e-05	0.0342	CrCbGaD
Mesalazine—Salicylic acid—PTGS1—ulcerative colitis	2.78e-05	0.0333	CrCbGaD
Mesalazine—Diflunisal—ALB—ulcerative colitis	2.55e-05	0.0305	CrCbGaD
Mesalazine—Salicylic acid—PTGS2—ulcerative colitis	1.59e-05	0.0191	CrCbGaD
Mesalazine—Salicylic acid—ALB—ulcerative colitis	1.42e-05	0.017	CrCbGaD
Mesalazine—Salicylic acid—ABCB1—ulcerative colitis	1.35e-05	0.0162	CrCbGaD
Mesalazine—Cough—Triamcinolone—ulcerative colitis	9.61e-06	0.000465	CcSEcCtD
Mesalazine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	9.54e-06	0.000462	CcSEcCtD
Mesalazine—Oedema—Hydrocortisone—ulcerative colitis	9.54e-06	0.000462	CcSEcCtD
Mesalazine—Tachycardia—Prednisolone—ulcerative colitis	9.54e-06	0.000461	CcSEcCtD
Mesalazine—Hypertension—Triamcinolone—ulcerative colitis	9.51e-06	0.00046	CcSEcCtD
Mesalazine—Hypertension—Methylprednisolone—ulcerative colitis	9.48e-06	0.000459	CcSEcCtD
Mesalazine—Infection—Hydrocortisone—ulcerative colitis	9.48e-06	0.000459	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisolone—ulcerative colitis	9.45e-06	0.000457	CcSEcCtD
Mesalazine—Shock—Hydrocortisone—ulcerative colitis	9.39e-06	0.000454	CcSEcCtD
Mesalazine—Myalgia—Triamcinolone—ulcerative colitis	9.37e-06	0.000453	CcSEcCtD
Mesalazine—Vomiting—Azathioprine—ulcerative colitis	9.37e-06	0.000453	CcSEcCtD
Mesalazine—Nervous system disorder—Hydrocortisone—ulcerative colitis	9.36e-06	0.000453	CcSEcCtD
Mesalazine—Myalgia—Methylprednisolone—ulcerative colitis	9.35e-06	0.000452	CcSEcCtD
Mesalazine—Arthralgia—Methylprednisolone—ulcerative colitis	9.35e-06	0.000452	CcSEcCtD
Mesalazine—Eye disorder—Prednisone—ulcerative colitis	9.34e-06	0.000452	CcSEcCtD
Mesalazine—Anxiety—Methylprednisolone—ulcerative colitis	9.32e-06	0.000451	CcSEcCtD
Mesalazine—Tachycardia—Hydrocortisone—ulcerative colitis	9.31e-06	0.000451	CcSEcCtD
Mesalazine—Rash—Azathioprine—ulcerative colitis	9.29e-06	0.000449	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	9.29e-06	0.000449	CcSEcCtD
Mesalazine—Dermatitis—Azathioprine—ulcerative colitis	9.28e-06	0.000449	CcSEcCtD
Mesalazine—Skin disorder—Hydrocortisone—ulcerative colitis	9.27e-06	0.000448	CcSEcCtD
Mesalazine—Ill-defined disorder—Betamethasone—ulcerative colitis	9.27e-06	0.000448	CcSEcCtD
Mesalazine—Ill-defined disorder—Dexamethasone—ulcerative colitis	9.27e-06	0.000448	CcSEcCtD
Mesalazine—Discomfort—Triamcinolone—ulcerative colitis	9.26e-06	0.000448	CcSEcCtD
Mesalazine—Discomfort—Methylprednisolone—ulcerative colitis	9.24e-06	0.000447	CcSEcCtD
Mesalazine—Headache—Azathioprine—ulcerative colitis	9.23e-06	0.000447	CcSEcCtD
Mesalazine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	9.22e-06	0.000446	CcSEcCtD
Mesalazine—Dry mouth—Triamcinolone—ulcerative colitis	9.17e-06	0.000443	CcSEcCtD
Mesalazine—Angioedema—Dexamethasone—ulcerative colitis	9.13e-06	0.000442	CcSEcCtD
Mesalazine—Angioedema—Betamethasone—ulcerative colitis	9.13e-06	0.000442	CcSEcCtD
Mesalazine—Anorexia—Hydrocortisone—ulcerative colitis	9.1e-06	0.00044	CcSEcCtD
Mesalazine—Angiopathy—Prednisone—ulcerative colitis	9.07e-06	0.000439	CcSEcCtD
Mesalazine—Confusional state—Methylprednisolone—ulcerative colitis	9.04e-06	0.000437	CcSEcCtD
Mesalazine—Immune system disorder—Prednisone—ulcerative colitis	9.03e-06	0.000437	CcSEcCtD
Mesalazine—Malaise—Dexamethasone—ulcerative colitis	9.01e-06	0.000436	CcSEcCtD
Mesalazine—Malaise—Betamethasone—ulcerative colitis	9.01e-06	0.000436	CcSEcCtD
Mesalazine—Oedema—Triamcinolone—ulcerative colitis	8.99e-06	0.000435	CcSEcCtD
Mesalazine—Anaphylactic shock—Triamcinolone—ulcerative colitis	8.99e-06	0.000435	CcSEcCtD
Mesalazine—Vertigo—Betamethasone—ulcerative colitis	8.97e-06	0.000434	CcSEcCtD
Mesalazine—Vertigo—Dexamethasone—ulcerative colitis	8.97e-06	0.000434	CcSEcCtD
Mesalazine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	8.97e-06	0.000434	CcSEcCtD
Mesalazine—Syncope—Dexamethasone—ulcerative colitis	8.96e-06	0.000433	CcSEcCtD
Mesalazine—Syncope—Betamethasone—ulcerative colitis	8.96e-06	0.000433	CcSEcCtD
Mesalazine—Infection—Triamcinolone—ulcerative colitis	8.93e-06	0.000432	CcSEcCtD
Mesalazine—Hypotension—Hydrocortisone—ulcerative colitis	8.92e-06	0.000431	CcSEcCtD
Mesalazine—Infection—Methylprednisolone—ulcerative colitis	8.91e-06	0.000431	CcSEcCtD
Mesalazine—Shock—Triamcinolone—ulcerative colitis	8.84e-06	0.000428	CcSEcCtD
Mesalazine—Insomnia—Prednisolone—ulcerative colitis	8.84e-06	0.000428	CcSEcCtD
Mesalazine—Alopecia—Prednisone—ulcerative colitis	8.83e-06	0.000427	CcSEcCtD
Mesalazine—Shock—Methylprednisolone—ulcerative colitis	8.82e-06	0.000427	CcSEcCtD
Mesalazine—Nervous system disorder—Methylprednisolone—ulcerative colitis	8.79e-06	0.000425	CcSEcCtD
Mesalazine—Loss of consciousness—Dexamethasone—ulcerative colitis	8.78e-06	0.000425	CcSEcCtD
Mesalazine—Loss of consciousness—Betamethasone—ulcerative colitis	8.78e-06	0.000425	CcSEcCtD
Mesalazine—Paraesthesia—Prednisolone—ulcerative colitis	8.77e-06	0.000424	CcSEcCtD
Mesalazine—Tachycardia—Triamcinolone—ulcerative colitis	8.77e-06	0.000424	CcSEcCtD
Mesalazine—Mental disorder—Prednisone—ulcerative colitis	8.76e-06	0.000424	CcSEcCtD
Mesalazine—Nausea—Azathioprine—ulcerative colitis	8.75e-06	0.000423	CcSEcCtD
Mesalazine—Tachycardia—Methylprednisolone—ulcerative colitis	8.75e-06	0.000423	CcSEcCtD
Mesalazine—Skin disorder—Methylprednisolone—ulcerative colitis	8.71e-06	0.000421	CcSEcCtD
Mesalazine—Erythema—Prednisone—ulcerative colitis	8.7e-06	0.000421	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.69e-06	0.000421	CcSEcCtD
Mesalazine—Hyperhidrosis—Triamcinolone—ulcerative colitis	8.69e-06	0.00042	CcSEcCtD
Mesalazine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	8.67e-06	0.000419	CcSEcCtD
Mesalazine—Insomnia—Hydrocortisone—ulcerative colitis	8.63e-06	0.000418	CcSEcCtD
Mesalazine—Hypertension—Betamethasone—ulcerative colitis	8.62e-06	0.000417	CcSEcCtD
Mesalazine—Hypertension—Dexamethasone—ulcerative colitis	8.62e-06	0.000417	CcSEcCtD
Mesalazine—Paraesthesia—Hydrocortisone—ulcerative colitis	8.57e-06	0.000415	CcSEcCtD
Mesalazine—Myalgia—Dexamethasone—ulcerative colitis	8.5e-06	0.000411	CcSEcCtD
Mesalazine—Myalgia—Betamethasone—ulcerative colitis	8.5e-06	0.000411	CcSEcCtD
Mesalazine—Anxiety—Dexamethasone—ulcerative colitis	8.48e-06	0.00041	CcSEcCtD
Mesalazine—Anxiety—Betamethasone—ulcerative colitis	8.48e-06	0.00041	CcSEcCtD
Mesalazine—Discomfort—Betamethasone—ulcerative colitis	8.4e-06	0.000407	CcSEcCtD
Mesalazine—Discomfort—Dexamethasone—ulcerative colitis	8.4e-06	0.000407	CcSEcCtD
Mesalazine—Dyspepsia—Hydrocortisone—ulcerative colitis	8.4e-06	0.000406	CcSEcCtD
Mesalazine—Hypotension—Methylprednisolone—ulcerative colitis	8.38e-06	0.000405	CcSEcCtD
Mesalazine—Pain—Prednisolone—ulcerative colitis	8.36e-06	0.000404	CcSEcCtD
Mesalazine—Decreased appetite—Hydrocortisone—ulcerative colitis	8.3e-06	0.000401	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	8.24e-06	0.000399	CcSEcCtD
Mesalazine—Fatigue—Hydrocortisone—ulcerative colitis	8.23e-06	0.000398	CcSEcCtD
Mesalazine—Vision blurred—Prednisone—ulcerative colitis	8.2e-06	0.000397	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	8.19e-06	0.000396	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	8.17e-06	0.000395	CcSEcCtD
Mesalazine—Pain—Hydrocortisone—ulcerative colitis	8.16e-06	0.000395	CcSEcCtD
Mesalazine—Anaphylactic shock—Dexamethasone—ulcerative colitis	8.15e-06	0.000394	CcSEcCtD
Mesalazine—Anaphylactic shock—Betamethasone—ulcerative colitis	8.15e-06	0.000394	CcSEcCtD
Mesalazine—Oedema—Betamethasone—ulcerative colitis	8.15e-06	0.000394	CcSEcCtD
Mesalazine—Oedema—Dexamethasone—ulcerative colitis	8.15e-06	0.000394	CcSEcCtD
Mesalazine—Insomnia—Triamcinolone—ulcerative colitis	8.13e-06	0.000393	CcSEcCtD
Mesalazine—Insomnia—Methylprednisolone—ulcerative colitis	8.11e-06	0.000392	CcSEcCtD
Mesalazine—Infection—Betamethasone—ulcerative colitis	8.1e-06	0.000392	CcSEcCtD
Mesalazine—Infection—Dexamethasone—ulcerative colitis	8.1e-06	0.000392	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisone—ulcerative colitis	8.07e-06	0.000391	CcSEcCtD
Mesalazine—Paraesthesia—Triamcinolone—ulcerative colitis	8.07e-06	0.00039	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisolone—ulcerative colitis	8.05e-06	0.00039	CcSEcCtD
Mesalazine—Paraesthesia—Methylprednisolone—ulcerative colitis	8.05e-06	0.000389	CcSEcCtD
Mesalazine—Anaemia—Prednisone—ulcerative colitis	8.04e-06	0.000389	CcSEcCtD
Mesalazine—Shock—Betamethasone—ulcerative colitis	8.02e-06	0.000388	CcSEcCtD
Mesalazine—Shock—Dexamethasone—ulcerative colitis	8.02e-06	0.000388	CcSEcCtD
Mesalazine—Dyspnoea—Triamcinolone—ulcerative colitis	8.01e-06	0.000388	CcSEcCtD
Mesalazine—Nervous system disorder—Betamethasone—ulcerative colitis	8e-06	0.000387	CcSEcCtD
Mesalazine—Nervous system disorder—Dexamethasone—ulcerative colitis	8e-06	0.000387	CcSEcCtD
Mesalazine—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.98e-06	0.000386	CcSEcCtD
Mesalazine—Thrombocytopenia—Betamethasone—ulcerative colitis	7.98e-06	0.000386	CcSEcCtD
Mesalazine—Tachycardia—Dexamethasone—ulcerative colitis	7.96e-06	0.000385	CcSEcCtD
Mesalazine—Tachycardia—Betamethasone—ulcerative colitis	7.96e-06	0.000385	CcSEcCtD
Mesalazine—Angioedema—Prednisone—ulcerative colitis	7.95e-06	0.000385	CcSEcCtD
Mesalazine—Dyspepsia—Triamcinolone—ulcerative colitis	7.91e-06	0.000383	CcSEcCtD
Mesalazine—Dyspepsia—Methylprednisolone—ulcerative colitis	7.89e-06	0.000382	CcSEcCtD
Mesalazine—Hyperhidrosis—Betamethasone—ulcerative colitis	7.88e-06	0.000381	CcSEcCtD
Mesalazine—Hyperhidrosis—Dexamethasone—ulcerative colitis	7.88e-06	0.000381	CcSEcCtD
Mesalazine—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.86e-06	0.00038	CcSEcCtD
Mesalazine—Malaise—Prednisone—ulcerative colitis	7.85e-06	0.00038	CcSEcCtD
Mesalazine—Vertigo—Prednisone—ulcerative colitis	7.82e-06	0.000378	CcSEcCtD
Mesalazine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	7.8e-06	0.000378	CcSEcCtD
Mesalazine—Syncope—Prednisone—ulcerative colitis	7.8e-06	0.000377	CcSEcCtD
Mesalazine—Anorexia—Dexamethasone—ulcerative colitis	7.77e-06	0.000376	CcSEcCtD
Mesalazine—Anorexia—Betamethasone—ulcerative colitis	7.77e-06	0.000376	CcSEcCtD
Mesalazine—Urticaria—Prednisolone—ulcerative colitis	7.76e-06	0.000376	CcSEcCtD
Mesalazine—Fatigue—Triamcinolone—ulcerative colitis	7.75e-06	0.000375	CcSEcCtD
Mesalazine—Fatigue—Methylprednisolone—ulcerative colitis	7.73e-06	0.000374	CcSEcCtD
Mesalazine—Pain—Triamcinolone—ulcerative colitis	7.68e-06	0.000372	CcSEcCtD
Mesalazine—Loss of consciousness—Prednisone—ulcerative colitis	7.65e-06	0.00037	CcSEcCtD
Mesalazine—Hypotension—Dexamethasone—ulcerative colitis	7.62e-06	0.000369	CcSEcCtD
Mesalazine—Hypotension—Betamethasone—ulcerative colitis	7.62e-06	0.000369	CcSEcCtD
Mesalazine—Urticaria—Hydrocortisone—ulcerative colitis	7.58e-06	0.000367	CcSEcCtD
Mesalazine—Body temperature increased—Hydrocortisone—ulcerative colitis	7.54e-06	0.000365	CcSEcCtD
Mesalazine—Abdominal pain—Hydrocortisone—ulcerative colitis	7.54e-06	0.000365	CcSEcCtD
Mesalazine—Hypertension—Prednisone—ulcerative colitis	7.51e-06	0.000363	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	7.43e-06	0.000359	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	7.43e-06	0.000359	CcSEcCtD
Mesalazine—Arthralgia—Prednisone—ulcerative colitis	7.41e-06	0.000358	CcSEcCtD
Mesalazine—Myalgia—Prednisone—ulcerative colitis	7.41e-06	0.000358	CcSEcCtD
Mesalazine—Feeling abnormal—Triamcinolone—ulcerative colitis	7.4e-06	0.000358	CcSEcCtD
Mesalazine—Feeling abnormal—Methylprednisolone—ulcerative colitis	7.39e-06	0.000357	CcSEcCtD
Mesalazine—Anxiety—Prednisone—ulcerative colitis	7.38e-06	0.000357	CcSEcCtD
Mesalazine—Insomnia—Dexamethasone—ulcerative colitis	7.37e-06	0.000357	CcSEcCtD
Mesalazine—Insomnia—Betamethasone—ulcerative colitis	7.37e-06	0.000357	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	7.36e-06	0.000356	CcSEcCtD
Mesalazine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	7.33e-06	0.000355	CcSEcCtD
Mesalazine—Paraesthesia—Dexamethasone—ulcerative colitis	7.32e-06	0.000354	CcSEcCtD
Mesalazine—Paraesthesia—Betamethasone—ulcerative colitis	7.32e-06	0.000354	CcSEcCtD
Mesalazine—Discomfort—Prednisone—ulcerative colitis	7.32e-06	0.000354	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisolone—ulcerative colitis	7.2e-06	0.000348	CcSEcCtD
Mesalazine—Dyspepsia—Betamethasone—ulcerative colitis	7.18e-06	0.000347	CcSEcCtD
Mesalazine—Dyspepsia—Dexamethasone—ulcerative colitis	7.18e-06	0.000347	CcSEcCtD
Mesalazine—Urticaria—Triamcinolone—ulcerative colitis	7.14e-06	0.000345	CcSEcCtD
Mesalazine—Urticaria—Methylprednisolone—ulcerative colitis	7.12e-06	0.000345	CcSEcCtD
Mesalazine—Body temperature increased—Triamcinolone—ulcerative colitis	7.1e-06	0.000344	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisone—ulcerative colitis	7.1e-06	0.000343	CcSEcCtD
Mesalazine—Oedema—Prednisone—ulcerative colitis	7.1e-06	0.000343	CcSEcCtD
Mesalazine—Abdominal pain—Methylprednisolone—ulcerative colitis	7.09e-06	0.000343	CcSEcCtD
Mesalazine—Decreased appetite—Dexamethasone—ulcerative colitis	7.09e-06	0.000343	CcSEcCtD
Mesalazine—Decreased appetite—Betamethasone—ulcerative colitis	7.09e-06	0.000343	CcSEcCtD
Mesalazine—Infection—Prednisone—ulcerative colitis	7.05e-06	0.000341	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	7.04e-06	0.000341	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	7.04e-06	0.000341	CcSEcCtD
Mesalazine—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.03e-06	0.00034	CcSEcCtD
Mesalazine—Fatigue—Dexamethasone—ulcerative colitis	7.03e-06	0.00034	CcSEcCtD
Mesalazine—Fatigue—Betamethasone—ulcerative colitis	7.03e-06	0.00034	CcSEcCtD
Mesalazine—Shock—Prednisone—ulcerative colitis	6.99e-06	0.000338	CcSEcCtD
Mesalazine—Pain—Betamethasone—ulcerative colitis	6.97e-06	0.000337	CcSEcCtD
Mesalazine—Pain—Dexamethasone—ulcerative colitis	6.97e-06	0.000337	CcSEcCtD
Mesalazine—Nervous system disorder—Prednisone—ulcerative colitis	6.96e-06	0.000337	CcSEcCtD
Mesalazine—Tachycardia—Prednisone—ulcerative colitis	6.93e-06	0.000335	CcSEcCtD
Mesalazine—Skin disorder—Prednisone—ulcerative colitis	6.9e-06	0.000334	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisone—ulcerative colitis	6.86e-06	0.000332	CcSEcCtD
Mesalazine—Asthenia—Hydrocortisone—ulcerative colitis	6.85e-06	0.000331	CcSEcCtD
Mesalazine—Anorexia—Prednisone—ulcerative colitis	6.77e-06	0.000327	CcSEcCtD
Mesalazine—Pruritus—Hydrocortisone—ulcerative colitis	6.75e-06	0.000327	CcSEcCtD
Mesalazine—Feeling abnormal—Betamethasone—ulcerative colitis	6.72e-06	0.000325	CcSEcCtD
Mesalazine—Feeling abnormal—Dexamethasone—ulcerative colitis	6.72e-06	0.000325	CcSEcCtD
Mesalazine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	6.67e-06	0.000323	CcSEcCtD
Mesalazine—Gastrointestinal pain—Betamethasone—ulcerative colitis	6.67e-06	0.000323	CcSEcCtD
Mesalazine—Hypersensitivity—Triamcinolone—ulcerative colitis	6.62e-06	0.00032	CcSEcCtD
Mesalazine—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.61e-06	0.00032	CcSEcCtD
Mesalazine—Diarrhoea—Hydrocortisone—ulcerative colitis	6.53e-06	0.000316	CcSEcCtD
Mesalazine—Urticaria—Dexamethasone—ulcerative colitis	6.48e-06	0.000313	CcSEcCtD
Mesalazine—Urticaria—Betamethasone—ulcerative colitis	6.48e-06	0.000313	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.47e-06	0.000313	CcSEcCtD
Mesalazine—Dizziness—Prednisolone—ulcerative colitis	6.46e-06	0.000313	CcSEcCtD
Mesalazine—Asthenia—Triamcinolone—ulcerative colitis	6.45e-06	0.000312	CcSEcCtD
Mesalazine—Body temperature increased—Dexamethasone—ulcerative colitis	6.44e-06	0.000312	CcSEcCtD
Mesalazine—Body temperature increased—Betamethasone—ulcerative colitis	6.44e-06	0.000312	CcSEcCtD
Mesalazine—Abdominal pain—Dexamethasone—ulcerative colitis	6.44e-06	0.000312	CcSEcCtD
Mesalazine—Abdominal pain—Betamethasone—ulcerative colitis	6.44e-06	0.000312	CcSEcCtD
Mesalazine—Asthenia—Methylprednisolone—ulcerative colitis	6.43e-06	0.000311	CcSEcCtD
Mesalazine—Insomnia—Prednisone—ulcerative colitis	6.42e-06	0.000311	CcSEcCtD
Mesalazine—Paraesthesia—Prednisone—ulcerative colitis	6.38e-06	0.000308	CcSEcCtD
Mesalazine—Pruritus—Triamcinolone—ulcerative colitis	6.36e-06	0.000308	CcSEcCtD
Mesalazine—Pruritus—Methylprednisolone—ulcerative colitis	6.34e-06	0.000307	CcSEcCtD
Mesalazine—Dizziness—Hydrocortisone—ulcerative colitis	6.31e-06	0.000305	CcSEcCtD
Mesalazine—Dyspepsia—Prednisone—ulcerative colitis	6.25e-06	0.000302	CcSEcCtD
Mesalazine—Decreased appetite—Prednisone—ulcerative colitis	6.17e-06	0.000299	CcSEcCtD
Mesalazine—Rash—Prednisolone—ulcerative colitis	6.16e-06	0.000298	CcSEcCtD
Mesalazine—Dermatitis—Prednisolone—ulcerative colitis	6.15e-06	0.000298	CcSEcCtD
Mesalazine—Diarrhoea—Methylprednisolone—ulcerative colitis	6.13e-06	0.000297	CcSEcCtD
Mesalazine—Fatigue—Prednisone—ulcerative colitis	6.12e-06	0.000296	CcSEcCtD
Mesalazine—Headache—Prednisolone—ulcerative colitis	6.12e-06	0.000296	CcSEcCtD
Mesalazine—Constipation—Prednisone—ulcerative colitis	6.07e-06	0.000294	CcSEcCtD
Mesalazine—Vomiting—Hydrocortisone—ulcerative colitis	6.07e-06	0.000294	CcSEcCtD
Mesalazine—Rash—Hydrocortisone—ulcerative colitis	6.02e-06	0.000291	CcSEcCtD
Mesalazine—Dermatitis—Hydrocortisone—ulcerative colitis	6.01e-06	0.000291	CcSEcCtD
Mesalazine—Headache—Hydrocortisone—ulcerative colitis	5.98e-06	0.000289	CcSEcCtD
Mesalazine—Dizziness—Triamcinolone—ulcerative colitis	5.94e-06	0.000287	CcSEcCtD
Mesalazine—Dizziness—Methylprednisolone—ulcerative colitis	5.93e-06	0.000287	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisone—ulcerative colitis	5.85e-06	0.000283	CcSEcCtD
Mesalazine—Asthenia—Dexamethasone—ulcerative colitis	5.85e-06	0.000283	CcSEcCtD
Mesalazine—Asthenia—Betamethasone—ulcerative colitis	5.85e-06	0.000283	CcSEcCtD
Mesalazine—Gastrointestinal pain—Prednisone—ulcerative colitis	5.81e-06	0.000281	CcSEcCtD
Mesalazine—Nausea—Prednisolone—ulcerative colitis	5.8e-06	0.000281	CcSEcCtD
Mesalazine—Pruritus—Dexamethasone—ulcerative colitis	5.77e-06	0.000279	CcSEcCtD
Mesalazine—Pruritus—Betamethasone—ulcerative colitis	5.77e-06	0.000279	CcSEcCtD
Mesalazine—Vomiting—Triamcinolone—ulcerative colitis	5.71e-06	0.000276	CcSEcCtD
Mesalazine—Vomiting—Methylprednisolone—ulcerative colitis	5.7e-06	0.000276	CcSEcCtD
Mesalazine—Nausea—Hydrocortisone—ulcerative colitis	5.67e-06	0.000274	CcSEcCtD
Mesalazine—Rash—Triamcinolone—ulcerative colitis	5.67e-06	0.000274	CcSEcCtD
Mesalazine—Dermatitis—Triamcinolone—ulcerative colitis	5.66e-06	0.000274	CcSEcCtD
Mesalazine—Rash—Methylprednisolone—ulcerative colitis	5.65e-06	0.000273	CcSEcCtD
Mesalazine—Dermatitis—Methylprednisolone—ulcerative colitis	5.65e-06	0.000273	CcSEcCtD
Mesalazine—Urticaria—Prednisone—ulcerative colitis	5.64e-06	0.000273	CcSEcCtD
Mesalazine—Headache—Triamcinolone—ulcerative colitis	5.63e-06	0.000272	CcSEcCtD
Mesalazine—Headache—Methylprednisolone—ulcerative colitis	5.62e-06	0.000272	CcSEcCtD
Mesalazine—Body temperature increased—Prednisone—ulcerative colitis	5.61e-06	0.000272	CcSEcCtD
Mesalazine—Abdominal pain—Prednisone—ulcerative colitis	5.61e-06	0.000272	CcSEcCtD
Mesalazine—Diarrhoea—Dexamethasone—ulcerative colitis	5.58e-06	0.00027	CcSEcCtD
Mesalazine—Diarrhoea—Betamethasone—ulcerative colitis	5.58e-06	0.00027	CcSEcCtD
Mesalazine—Dizziness—Betamethasone—ulcerative colitis	5.39e-06	0.000261	CcSEcCtD
Mesalazine—Dizziness—Dexamethasone—ulcerative colitis	5.39e-06	0.000261	CcSEcCtD
Mesalazine—Nausea—Triamcinolone—ulcerative colitis	5.34e-06	0.000258	CcSEcCtD
Mesalazine—Nausea—Methylprednisolone—ulcerative colitis	5.33e-06	0.000258	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisone—ulcerative colitis	5.23e-06	0.000253	CcSEcCtD
Mesalazine—Vomiting—Dexamethasone—ulcerative colitis	5.18e-06	0.000251	CcSEcCtD
Mesalazine—Vomiting—Betamethasone—ulcerative colitis	5.18e-06	0.000251	CcSEcCtD
Mesalazine—Rash—Dexamethasone—ulcerative colitis	5.14e-06	0.000249	CcSEcCtD
Mesalazine—Rash—Betamethasone—ulcerative colitis	5.14e-06	0.000249	CcSEcCtD
Mesalazine—Dermatitis—Dexamethasone—ulcerative colitis	5.14e-06	0.000248	CcSEcCtD
Mesalazine—Dermatitis—Betamethasone—ulcerative colitis	5.14e-06	0.000248	CcSEcCtD
Mesalazine—Headache—Dexamethasone—ulcerative colitis	5.11e-06	0.000247	CcSEcCtD
Mesalazine—Headache—Betamethasone—ulcerative colitis	5.11e-06	0.000247	CcSEcCtD
Mesalazine—Asthenia—Prednisone—ulcerative colitis	5.09e-06	0.000246	CcSEcCtD
Mesalazine—Pruritus—Prednisone—ulcerative colitis	5.02e-06	0.000243	CcSEcCtD
Mesalazine—Diarrhoea—Prednisone—ulcerative colitis	4.86e-06	0.000235	CcSEcCtD
Mesalazine—Nausea—Betamethasone—ulcerative colitis	4.84e-06	0.000234	CcSEcCtD
Mesalazine—Nausea—Dexamethasone—ulcerative colitis	4.84e-06	0.000234	CcSEcCtD
Mesalazine—Dizziness—Prednisone—ulcerative colitis	4.69e-06	0.000227	CcSEcCtD
Mesalazine—Vomiting—Prednisone—ulcerative colitis	4.51e-06	0.000218	CcSEcCtD
Mesalazine—Rash—Prednisone—ulcerative colitis	4.48e-06	0.000217	CcSEcCtD
Mesalazine—Dermatitis—Prednisone—ulcerative colitis	4.47e-06	0.000216	CcSEcCtD
Mesalazine—Headache—Prednisone—ulcerative colitis	4.45e-06	0.000215	CcSEcCtD
Mesalazine—Nausea—Prednisone—ulcerative colitis	4.22e-06	0.000204	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.21e-06	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ITGAL—ulcerative colitis	4.2e-06	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DQA1—ulcerative colitis	4.2e-06	0.000208	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.18e-06	0.000207	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	4.18e-06	0.000207	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—JAK2—ulcerative colitis	4.13e-06	0.000204	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—ulcerative colitis	4.11e-06	0.000204	CbGpPWpGaD
Mesalazine—CHUK—Disease—SLC11A1—ulcerative colitis	4.1e-06	0.000203	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ADCY5—ulcerative colitis	4.09e-06	0.000203	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	4.09e-06	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SEL1L—ulcerative colitis	4.07e-06	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—JAK2—ulcerative colitis	4.06e-06	0.000201	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—ulcerative colitis	4.05e-06	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—ulcerative colitis	4.04e-06	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—ulcerative colitis	4.04e-06	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FCGR2A—ulcerative colitis	4.02e-06	0.000199	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CHP1—ulcerative colitis	4.01e-06	0.000198	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—RELA—ulcerative colitis	4e-06	0.000198	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IRF5—ulcerative colitis	3.99e-06	0.000198	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	3.98e-06	0.000197	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—ulcerative colitis	3.97e-06	0.000197	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—ulcerative colitis	3.95e-06	0.000195	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—RELA—ulcerative colitis	3.93e-06	0.000195	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.93e-06	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—ulcerative colitis	3.87e-06	0.000191	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTPN2—ulcerative colitis	3.85e-06	0.000191	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CCR6—ulcerative colitis	3.82e-06	0.000189	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IRF8—ulcerative colitis	3.82e-06	0.000189	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—ulcerative colitis	3.8e-06	0.000188	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SEL1L—ulcerative colitis	3.8e-06	0.000188	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.75e-06	0.000186	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	3.72e-06	0.000184	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ADCY5—ulcerative colitis	3.71e-06	0.000184	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	3.71e-06	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCR1—ulcerative colitis	3.7e-06	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAML2—ulcerative colitis	3.69e-06	0.000182	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—ulcerative colitis	3.66e-06	0.000181	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	3.66e-06	0.000181	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NFKB1—ulcerative colitis	3.65e-06	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FCGR2A—ulcerative colitis	3.64e-06	0.00018	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—ulcerative colitis	3.63e-06	0.00018	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—ulcerative colitis	3.62e-06	0.000179	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	3.61e-06	0.000179	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—ulcerative colitis	3.6e-06	0.000178	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—ulcerative colitis	3.6e-06	0.000178	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—ulcerative colitis	3.58e-06	0.000177	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—ulcerative colitis	3.58e-06	0.000177	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—ulcerative colitis	3.54e-06	0.000175	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTPN2—ulcerative colitis	3.49e-06	0.000173	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	3.49e-06	0.000173	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—ulcerative colitis	3.48e-06	0.000172	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.46e-06	0.000171	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—DLD—ulcerative colitis	3.46e-06	0.000171	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TLR4—ulcerative colitis	3.43e-06	0.00017	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	3.42e-06	0.000169	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LTF—ulcerative colitis	3.41e-06	0.000169	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ABCB1—ulcerative colitis	3.4e-06	0.000168	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	3.37e-06	0.000167	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—ulcerative colitis	3.37e-06	0.000167	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—ulcerative colitis	3.37e-06	0.000167	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	3.37e-06	0.000167	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCR1—ulcerative colitis	3.35e-06	0.000166	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	3.34e-06	0.000165	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—ulcerative colitis	3.34e-06	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—NFKB1—ulcerative colitis	3.31e-06	0.000164	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—ulcerative colitis	3.31e-06	0.000164	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DRB1—ulcerative colitis	3.29e-06	0.000163	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—ulcerative colitis	3.29e-06	0.000163	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CALM3—ulcerative colitis	3.29e-06	0.000163	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—STAT3—ulcerative colitis	3.28e-06	0.000163	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL20—ulcerative colitis	3.25e-06	0.000161	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—ulcerative colitis	3.25e-06	0.000161	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—ulcerative colitis	3.24e-06	0.00016	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RIPK2—ulcerative colitis	3.24e-06	0.00016	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTLA4—ulcerative colitis	3.19e-06	0.000158	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ADCY5—ulcerative colitis	3.17e-06	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ICAM1—ulcerative colitis	3.16e-06	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR4—ulcerative colitis	3.11e-06	0.000154	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—JAK2—ulcerative colitis	3.08e-06	0.000152	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GNA12—ulcerative colitis	3.05e-06	0.000151	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	3.05e-06	0.000151	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—ulcerative colitis	3.04e-06	0.000151	CbGpPWpGaD
Mesalazine—CHUK—Disease—CALM3—ulcerative colitis	3.03e-06	0.00015	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	3.03e-06	0.00015	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	3.01e-06	0.000149	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS1—ulcerative colitis	3.01e-06	0.000149	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.99e-06	0.000148	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DRB1—ulcerative colitis	2.99e-06	0.000148	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	2.98e-06	0.000148	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—RELA—ulcerative colitis	2.98e-06	0.000148	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CALM3—ulcerative colitis	2.98e-06	0.000148	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—STAT3—ulcerative colitis	2.98e-06	0.000147	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.96e-06	0.000146	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL20—ulcerative colitis	2.95e-06	0.000146	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RIPK2—ulcerative colitis	2.94e-06	0.000145	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NOD2—ulcerative colitis	2.94e-06	0.000145	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD14—ulcerative colitis	2.92e-06	0.000145	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCR2—ulcerative colitis	2.9e-06	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTLA4—ulcerative colitis	2.89e-06	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ICAM1—ulcerative colitis	2.87e-06	0.000142	CbGpPWpGaD
Mesalazine—CHUK—Immune System—VCAM1—ulcerative colitis	2.82e-06	0.000139	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQA1—ulcerative colitis	2.81e-06	0.000139	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDH1—ulcerative colitis	2.8e-06	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GNA12—ulcerative colitis	2.77e-06	0.000137	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—ulcerative colitis	2.76e-06	0.000137	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	2.76e-06	0.000137	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR6—ulcerative colitis	2.72e-06	0.000135	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CALM3—ulcerative colitis	2.71e-06	0.000134	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—VDR—ulcerative colitis	2.7e-06	0.000134	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NOD2—ulcerative colitis	2.66e-06	0.000132	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD14—ulcerative colitis	2.65e-06	0.000131	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCR2—ulcerative colitis	2.63e-06	0.00013	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.59e-06	0.000128	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAML2—ulcerative colitis	2.58e-06	0.000128	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—VCAM1—ulcerative colitis	2.55e-06	0.000126	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—JAK2—ulcerative colitis	2.55e-06	0.000126	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQA1—ulcerative colitis	2.55e-06	0.000126	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—ulcerative colitis	2.54e-06	0.000126	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDH1—ulcerative colitis	2.54e-06	0.000126	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—NFKB1—ulcerative colitis	2.51e-06	0.000124	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.49e-06	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—RELA—ulcerative colitis	2.47e-06	0.000122	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR6—ulcerative colitis	2.47e-06	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC11A1—ulcerative colitis	2.43e-06	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—ulcerative colitis	2.42e-06	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTGER4—ulcerative colitis	2.4e-06	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ADCY5—ulcerative colitis	2.38e-06	0.000118	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—RELA—ulcerative colitis	2.37e-06	0.000118	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARG—ulcerative colitis	2.37e-06	0.000117	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAML2—ulcerative colitis	2.34e-06	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—ulcerative colitis	2.33e-06	0.000116	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.33e-06	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—ulcerative colitis	2.32e-06	0.000115	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—JAK2—ulcerative colitis	2.31e-06	0.000115	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.3e-06	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—ulcerative colitis	2.29e-06	0.000114	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—STAT3—ulcerative colitis	2.26e-06	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—RELA—ulcerative colitis	2.24e-06	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Disease—ADCY5—ulcerative colitis	2.2e-06	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GHRL—ulcerative colitis	2.19e-06	0.000109	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—ulcerative colitis	2.19e-06	0.000109	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAML2—ulcerative colitis	2.18e-06	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTGER4—ulcerative colitis	2.17e-06	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ADCY5—ulcerative colitis	2.16e-06	0.000107	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—RELA—ulcerative colitis	2.15e-06	0.000107	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—ulcerative colitis	2.13e-06	0.000105	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CALM3—ulcerative colitis	2.13e-06	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—ulcerative colitis	2.12e-06	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—ulcerative colitis	2.11e-06	0.000104	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCB1—ulcerative colitis	2.11e-06	0.000104	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—ulcerative colitis	2.09e-06	0.000104	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RIPK2—ulcerative colitis	2.09e-06	0.000104	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—ulcerative colitis	2.09e-06	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NFKB1—ulcerative colitis	2.08e-06	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—ulcerative colitis	2.08e-06	0.000103	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.07e-06	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.05e-06	0.000102	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—NFKB1—ulcerative colitis	2e-06	9.91e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR4—ulcerative colitis	2e-06	9.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DRB1—ulcerative colitis	2e-06	9.89e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GHRL—ulcerative colitis	1.99e-06	9.85e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADCY5—ulcerative colitis	1.96e-06	9.72e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—ulcerative colitis	1.96e-06	9.68e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CALM3—ulcerative colitis	1.93e-06	9.54e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ICAM1—ulcerative colitis	1.92e-06	9.5e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RIPK2—ulcerative colitis	1.9e-06	9.4e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CALM3—ulcerative colitis	1.9e-06	9.39e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—ulcerative colitis	1.89e-06	9.37e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NFKB1—ulcerative colitis	1.89e-06	9.36e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—ulcerative colitis	1.86e-06	9.22e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.83e-06	9.06e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADRB2—ulcerative colitis	1.82e-06	8.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—NFKB1—ulcerative colitis	1.82e-06	8.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR4—ulcerative colitis	1.81e-06	8.98e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.81e-06	8.97e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRB1—ulcerative colitis	1.81e-06	8.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CALM3—ulcerative colitis	1.8e-06	8.9e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ICAM1—ulcerative colitis	1.74e-06	8.61e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDH1—ulcerative colitis	1.7e-06	8.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.67e-06	8.28e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADRB2—ulcerative colitis	1.65e-06	8.15e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.64e-06	8.14e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—ulcerative colitis	1.58e-06	7.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADCY5—ulcerative colitis	1.54e-06	7.63e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDH1—ulcerative colitis	1.54e-06	7.61e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CALM3—ulcerative colitis	1.51e-06	7.45e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—JAK2—ulcerative colitis	1.49e-06	7.36e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCB1—ulcerative colitis	1.47e-06	7.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—ulcerative colitis	1.46e-06	7.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RELA—ulcerative colitis	1.44e-06	7.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—ulcerative colitis	1.41e-06	6.98e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADCY5—ulcerative colitis	1.4e-06	6.92e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADCY5—ulcerative colitis	1.38e-06	6.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—JAK2—ulcerative colitis	1.37e-06	6.8e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—JAK2—ulcerative colitis	1.35e-06	6.67e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—ulcerative colitis	1.32e-06	6.55e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—ulcerative colitis	1.32e-06	6.52e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—ulcerative colitis	1.31e-06	6.48e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RELA—ulcerative colitis	1.31e-06	6.46e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ADCY5—ulcerative colitis	1.3e-06	6.46e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—ulcerative colitis	1.3e-06	6.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—ulcerative colitis	1.3e-06	6.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—ulcerative colitis	1.3e-06	6.42e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—ulcerative colitis	1.29e-06	6.4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—ulcerative colitis	1.28e-06	6.33e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NFKB1—ulcerative colitis	1.21e-06	6.01e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—ulcerative colitis	1.19e-06	5.87e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—ulcerative colitis	1.18e-06	5.84e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—ulcerative colitis	1.18e-06	5.82e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCB1—ulcerative colitis	1.17e-06	5.8e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—ulcerative colitis	1.15e-06	5.7e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NFKB1—ulcerative colitis	1.1e-06	5.45e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADCY5—ulcerative colitis	1.09e-06	5.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—STAT3—ulcerative colitis	1.09e-06	5.4e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—ulcerative colitis	1.03e-06	5.08e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—STAT3—ulcerative colitis	1.01e-06	4.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—STAT3—ulcerative colitis	9.89e-07	4.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JAK2—ulcerative colitis	9.61e-07	4.76e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—ulcerative colitis	9.34e-07	4.62e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RELA—ulcerative colitis	9.31e-07	4.61e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—ulcerative colitis	9.23e-07	4.57e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—ulcerative colitis	8.77e-07	4.34e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JAK2—ulcerative colitis	8.72e-07	4.32e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RELA—ulcerative colitis	8.44e-07	4.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—ulcerative colitis	8.38e-07	4.15e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—ulcerative colitis	8.15e-07	4.03e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JAK2—ulcerative colitis	8.13e-07	4.03e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—ulcerative colitis	8.07e-07	4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—ulcerative colitis	7.95e-07	3.94e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—ulcerative colitis	7.93e-07	3.93e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NFKB1—ulcerative colitis	7.85e-07	3.89e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—ulcerative colitis	7.71e-07	3.82e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—ulcerative colitis	7.62e-07	3.77e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—ulcerative colitis	7.6e-07	3.76e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—ulcerative colitis	7.32e-07	3.63e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—ulcerative colitis	7.19e-07	3.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NFKB1—ulcerative colitis	7.12e-07	3.52e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STAT3—ulcerative colitis	7.05e-07	3.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—ulcerative colitis	7.04e-07	3.48e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—ulcerative colitis	6.91e-07	3.42e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—ulcerative colitis	6.54e-07	3.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT3—ulcerative colitis	6.4e-07	3.17e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—STAT3—ulcerative colitis	5.97e-07	2.95e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—ulcerative colitis	5.93e-07	2.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—ulcerative colitis	5.53e-07	2.74e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—ulcerative colitis	5.38e-07	2.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—ulcerative colitis	4.93e-07	2.44e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—ulcerative colitis	4.88e-07	2.42e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—ulcerative colitis	4.47e-07	2.21e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—ulcerative colitis	4.17e-07	2.06e-05	CbGpPWpGaD
